A detailed history of Concourse Financial Group Securities, Inc. transactions in Certara, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 306 shares of CERT stock, worth $3,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares
306
Previous 306 -0.0%
Holding current value
$3,460
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$15.65 - $19.45 $109 - $136
-7 Reduced 2.24%
306 $5,000
Q4 2023

Feb 07, 2024

SELL
$12.12 - $18.19 $1,066 - $1,600
-88 Reduced 21.95%
313 $5,000
Q3 2023

Oct 25, 2023

SELL
$13.9 - $19.58 $986 - $1,390
-71 Reduced 15.04%
401 $5,000
Q2 2023

Aug 10, 2023

SELL
$16.89 - $24.64 $675 - $985
-40 Reduced 7.81%
472 $8,000
Q1 2023

May 15, 2023

SELL
$15.9 - $24.72 $2,798 - $4,350
-176 Reduced 25.58%
512 $12,000
Q4 2022

Jan 30, 2023

SELL
$10.7 - $17.84 $1,391 - $2,319
-130 Reduced 15.89%
688 $0
Q3 2022

Nov 15, 2022

BUY
$12.84 - $24.13 $950 - $1,785
74 Added 9.95%
818 $11,000
Q2 2022

Aug 09, 2022

SELL
$16.75 - $22.54 $1,423 - $1,915
-85 Reduced 10.25%
744 $16,000
Q1 2022

May 09, 2022

SELL
$17.89 - $28.73 $15,206 - $24,420
-850 Reduced 50.63%
829 $18,000
Q4 2021

Feb 07, 2022

SELL
$26.1 - $45.21 $5,011 - $8,680
-192 Reduced 10.26%
1,679 $48,000
Q3 2021

Nov 09, 2021

BUY
$24.46 - $38.41 $45,764 - $71,865
1,871 New
1,871 $62,000
Q2 2021

Aug 13, 2021

BUY
$24.79 - $33.31 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021

BUY
$25.58 - $39.0 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021

BUY
$33.59 - $40.18 $0 - $0
0 New
0 $0

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $1.81B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.